MedPharm to Expand its UK Analytical Service Labs

Published on: 
In the Lab eNewsletter, Pharmaceutical Technology's In the Lab eNewsletter 06-02-2021, Volume 16, Issue 6

MedPharm’s £1.5-million (US$2.1-million) expansion of its Surrey, United Kingdom, facility will increase its UK laboratory space by 35% and enhance its topical and transdermal services.

MedPharm, a formulation development and analytical services company for topical and transdermal products, has invested £1.5 million (US$2.1 million) into the refurbishment and expansion of its 15,000-ft2 facility in Surrey, United Kingdom, increasing its UK laboratory space by 35%.

The expansion, which is set to be completed by the fourth quarter of 2021, will allow for a more efficient workflow and the ability for the company to continue to meet the demand for topical and transdermal services, MedPharm said in a May 20, 2021 company press release.

“We are excited to be renovating our formulation development and analytical laboratories, clinical manufacturing suites, and personnel workspace to ensure our operations and capabilities remain state of the art,” said Rob Turner, general manager UK, MedPharm, in the press release. “During the renovations, we will take extensive steps to de-risk the process and do not expect any disruption to our existing services, quality of scientific deliverables, and client commitments throughout the refurbishment.”


Source: MedPharm